Form 8-K - Current report:
SEC Accession No. 0000950170-23-000426
Filing Date
2023-01-09
Accepted
2023-01-09 07:01:26
Documents
64
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20230109.htm   iXBRL 8-K 53068
2 EX-99.1 rlay-ex99_1.htm EX-99.1 53117
3 GRAPHIC rlay-ex99_1s1.jpg GRAPHIC 161571
4 GRAPHIC rlay-ex99_1s2.jpg GRAPHIC 708334
5 GRAPHIC rlay-ex99_1s3.jpg GRAPHIC 306382
6 GRAPHIC rlay-ex99_1s4.jpg GRAPHIC 346145
7 GRAPHIC rlay-ex99_1s5.jpg GRAPHIC 363500
8 GRAPHIC rlay-ex99_1s6.jpg GRAPHIC 441307
9 GRAPHIC rlay-ex99_1s7.jpg GRAPHIC 385775
10 GRAPHIC rlay-ex99_1s8.jpg GRAPHIC 157725
11 GRAPHIC rlay-ex99_1s9.jpg GRAPHIC 242948
12 GRAPHIC rlay-ex99_1s10.jpg GRAPHIC 492927
13 GRAPHIC rlay-ex99_1s11.jpg GRAPHIC 408767
14 GRAPHIC rlay-ex99_1s12.jpg GRAPHIC 236492
15 GRAPHIC rlay-ex99_1s13.jpg GRAPHIC 434883
16 GRAPHIC rlay-ex99_1s14.jpg GRAPHIC 365429
17 GRAPHIC rlay-ex99_1s15.jpg GRAPHIC 329166
18 GRAPHIC rlay-ex99_1s16.jpg GRAPHIC 388118
19 GRAPHIC rlay-ex99_1s17.jpg GRAPHIC 488854
20 GRAPHIC rlay-ex99_1s18.jpg GRAPHIC 520338
21 GRAPHIC rlay-ex99_1s19.jpg GRAPHIC 517048
22 GRAPHIC rlay-ex99_1s20.jpg GRAPHIC 436333
23 GRAPHIC rlay-ex99_1s21.jpg GRAPHIC 387208
24 GRAPHIC rlay-ex99_1s22.jpg GRAPHIC 503364
25 GRAPHIC rlay-ex99_1s23.jpg GRAPHIC 419828
26 GRAPHIC rlay-ex99_1s24.jpg GRAPHIC 280470
27 GRAPHIC rlay-ex99_1s25.jpg GRAPHIC 368947
28 GRAPHIC rlay-ex99_1s26.jpg GRAPHIC 403707
29 GRAPHIC rlay-ex99_1s27.jpg GRAPHIC 233353
30 GRAPHIC rlay-ex99_1s28.jpg GRAPHIC 399181
31 GRAPHIC rlay-ex99_1s29.jpg GRAPHIC 580660
32 GRAPHIC rlay-ex99_1s30.jpg GRAPHIC 402880
33 GRAPHIC rlay-ex99_1s31.jpg GRAPHIC 312617
34 GRAPHIC rlay-ex99_1s32.jpg GRAPHIC 332591
35 GRAPHIC rlay-ex99_1s33.jpg GRAPHIC 404303
36 GRAPHIC rlay-ex99_1s34.jpg GRAPHIC 354455
37 GRAPHIC rlay-ex99_1s35.jpg GRAPHIC 403931
38 GRAPHIC rlay-ex99_1s36.jpg GRAPHIC 430107
39 GRAPHIC rlay-ex99_1s37.jpg GRAPHIC 298456
40 GRAPHIC rlay-ex99_1s38.jpg GRAPHIC 236166
41 GRAPHIC rlay-ex99_1s39.jpg GRAPHIC 361194
42 GRAPHIC rlay-ex99_1s40.jpg GRAPHIC 256934
43 GRAPHIC rlay-ex99_1s41.jpg GRAPHIC 388709
44 GRAPHIC rlay-ex99_1s42.jpg GRAPHIC 369193
45 GRAPHIC rlay-ex99_1s43.jpg GRAPHIC 332750
46 GRAPHIC rlay-ex99_1s44.jpg GRAPHIC 237221
47 GRAPHIC rlay-ex99_1s45.jpg GRAPHIC 406651
48 GRAPHIC rlay-ex99_1s46.jpg GRAPHIC 267323
49 GRAPHIC rlay-ex99_1s47.jpg GRAPHIC 301871
50 GRAPHIC rlay-ex99_1s48.jpg GRAPHIC 441406
51 GRAPHIC rlay-ex99_1s49.jpg GRAPHIC 385910
52 GRAPHIC rlay-ex99_1s50.jpg GRAPHIC 497406
53 GRAPHIC rlay-ex99_1s51.jpg GRAPHIC 130310
  Complete submission text file 0000950170-23-000426.txt   26211402

Data Files

Seq Description Document Type Size
54 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20230109.xsd EX-101.SCH 2454
55 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20230109_lab.xml EX-101.LAB 13474
56 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20230109_pre.xml EX-101.PRE 9890
58 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20230109_htm.xml XML 4754
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 23516508
SIC: 2836 Biological Products, (No Diagnostic Substances)